TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Salipro Biotech AB
Closing information (x1000 SEK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
5,968
|
7,468
|
4,509 |
Financial expenses |
1
|
0
![]() |
0 |
Earnings before taxes |
-4,264
|
-2,406
|
-1,941 |
EBITDA |
-3,709
|
-1,847
|
-1,463 |
Total assets |
15,620
|
19,625
|
21,967 |
Current assets |
9,545
|
14,270
|
17,060 |
Current liabilities |
1,733
|
1,474
|
1,410 |
Equity capital |
13,887
|
18,151
|
20,557 |
- share capital |
69
![]() |
69
![]() |
69 |
Employees (average) |
9
|
7
|
6 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
88.9%
|
92.5%
|
93.6% |
Turnover per employee |
663
|
1,067
|
752 |
Profit as a percentage of turnover |
-71.4%
|
-32.2%
|
-43.0% |
Return on assets (ROA) |
-27.3%
|
-12.3%
|
-8.8% |
Current ratio |
550.8%
|
968.1%
|
1209.9% |
Return on equity (ROE) |
-30.7%
|
-13.3%
|
-9.4% |
Change turnover |
-1,500
|
2,959
|
974 |
Change turnover % |
-20%
|
66%
|
28% |
Chg. No. of employees |
2
|
1
|
0 |
Chg. No. of employees % |
29%
|
17%
|
0% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.